Articles Posted in Xarelto

According to a recent report from WebMD News, a recent study, which asserted both Xarelto and Pradaxa were superior to Warfarin, found that Xarelto poses a higher risk of serious internal bleeding disorders than its competitor, Pradaxa. The drugs at issue are part of a new class of anticoagulants known as New Oral Anticoagulants (NOACs).  Xarelto, Pradaxa, Eliquis, and Savaysa are the four NOACs approved by the United States Food and Drug Administration (FDA).

untitled-1238929-mThe risk of increased internal bleeding disorders for patients taking Xarelto over patients taking Pradaxa was seen in patients who suffer from a serious medical condition known as atrial fibrillation (Afib).  Afib, is characterized by an irregular heartbeat not caused by a heart valve defect.  If this sounds familiar to you even though you do not suffer from Afib, it might be because Saturday Night Live alumni actor Kevin Nealon appears in a commercial where he discusses his own struggles with Afib and how taking Xarelto has helped him to lead a normal life. Continue reading

For many years, if someone needed a blood thinner, he or she would take Warfarin (Coumadin).  This product is relatively safe and there are not many side effects, so long as a person carefully monitors his or her diet and has regular blood tests so their doctor can check the blood chemistry to see how the drug is being absorbed.

prescription-300x201The reason it is important to monitor the absorption level of Warfarin is because if the level is off, it can result in a serious internal bleeding disorders.  While this is a serious concern, as this is no minor side effect, it is easy to avoid so long as you are compliant with your medication. In the event a patient has an internal bleeding disorder and goes to the emergency room, the ER doctors will be able to administer a reversal agent (antidote) that will stop the anti-clotting effect, which, in turn, will allow the body to clot again so the internal bleeding will stop.  It should be noted that reason it is important for a patient to monitor his or her diet is because certain foods high in vitamin K like dark greens will affect the absorption rate of Warfarin, and that can lead to serious problems. Continue reading

The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug.  Xarelto is a member of a relatively new class of drugs called New Oral Anticoagulants (NOACs).  NOACs are used for patients who suffer from a series of medical conditions including deep vein thrombosis (DVT) and atrial fibrillation (Afib).  Afib is a serious medical condition that causes an irregular heartbeat when the patient does not have a heart valve defect.

whitepillsIn addition to Xarelto, Pradaxa, Eliquis and Savaysa are members of this new class of NOACs.  Traditionally, before these medications were on the market, patients would take Warfarin (Coumadin) as a blood thinner.  Warfarin is known to work and is relatively safe as long as patients do what they are told to do by their doctors.  However, since patients do not always do what they are told, the drug is not always so convenient to take and may result in a serious internal bleeding disorder.  However, if a patient does suffer from internal bleeding, a doctor can prescribe a reversal agent (antidote) to allow the patient to clot normally so the bleeding will stop. Continue reading

There is no question that Xarelto has been linked to a lot of serious bleeding disorders, many of which resulted in death.  There are many reasons the drug has proven so dangerous to users, but a lot of the problems are result of the reportedly negligent manner in which Bayer and Janssen Pharmaceuticals performed the safety testing and informed the U.S. Food and Drug Administration (FDA) of the Results.

Pills pouring from a medication bottle

According to a recent news feature from Forbes, one plaintiff’s lawyer that handles Xarelto injury lawsuits states that these experiments were conducted in the same manner that young students would do in an elementary school science fair when making their projects.  Continue reading

A man from Florida has filed a new Xarelto injury lawsuit against Janssen Pharmaceuticals (a division of Johnson & Johnson, which is the U.S. marketing partner of Xarelto) and Bayer A.G. which is the German pharmaceutical giant that manufactures the medication. As part of this lawsuit, he is claiming negligent manufacture of a defective drug, among several other related claims.

perscription-drug-case-1156714-mThe lawsuit was filed in a United States District Court and technically has several more named defendants than listed above because each of these other companies have several wholly owned subsidiaries that were involved in the manufacture and marketing of Xarelto according to a recent news article from the Louisiana Record. Continue reading

A recent article from Medpage Today looks at new uses being proposed for a class of medications know as new oral anticoagulants (NOACs).  This is a fairly new class of medications that includes Xarelto, Eliquis, Pradaxa, and Savaysa.  These medications were designed primary to treat patients who suffer from a serious medical condition know as atrial fibrillation (Afib).

perscription-drugs-2-1160103-m-300x225As you have probably heard actor Kevin Nealon tell you during a commercial break, Afib is medical condition classified as a irregular heartbeat not caused by a heart valve defect.  A patient with Afib is at risk for developing blood clots that can cause serious and often deadly problems.  They can block the flow of blood to the brain.  This deprives the brain of much needed oxygen and is what happens when a patient has a stroke. The loss of blood can cause death or serious brain injury that can have life long effects. Continue reading

According to a recent news article from the Louisiana Record, the surviving daughter of a man from Ohio claims that her father died as a result of complications due to taking Xarelto.  The complaint was filed on April 8, 2016 in a United States District Court.  Plaintiff filed the suit against Janssen, which is the marketing arm of Johnson & Johnson and the United States marketing partner for Xarelto.  The plaintiff also named Bayer, which is the German pharmaceutical giant that manufactures Xarelto.packofpills

The claims included in the complaint are for fraud, breach of an express or implied warranty, defective design, failure to warn of a known danger, wrongful death, and negligent misrepresentation.  Continue reading

Janssen, which is a division of pharmaceutical giant Johnson & Johnson, is the U.S. marketing partner of Bayer, the German drugmaker that manufactures Xarelto, and has released a report that its new oral anticoagulant (NOAC) is superior to Warfarin (Coumadin) in reducing the risk of ischemic stroke, according to a recent news feature from Cardiovascular Business.

tylenolThe company also claims that Xarelto is superior to Warfarin in reducing the risk of intracranial hemorrhage. The reason patients take a blood thinner or oral anti-coagulant such as Xarelto is because they are at significant risk of developing blood clots due to a medical condition known as atrial fibrillation (Afib).  These clots can form in various places, including deep in the veins of the legs.  If they form in the legs, it is a potentially deadly medical condition known as deep vein thrombosis (DVT).  Continue reading

A recent feature from CBS News examined whether Johnson & Johnson and Bayer, the makers of Xarelto, knowingly withheld certain important data for a letter to be published in the New England Journal of Medicine.

nurse-1-1158314-mThe specific claim made by lawyers for Xarelto plaintiffs in the multi-district litigation (MDL) class action lawsuit is that the defendants purposely withheld information from results published involving a Duke University analysis of drug trial results.  This information relates to a blood testing device that was not functioning property.  The device was being used to test patients who were on Warfarin (Coumadin), which is the traditional alternative to Xarelto.  Continue reading

According to a recent news feature from the New York Times, the United States Food and Drug Administration (FDA) is now conducting an investigation into whether a blood testing device used during clinical trials, which we now know to be defective, led to an approval of Xarelto that never should have happened.

orangepillsXarelto is a member of new class of drugs known as new oral anticoagulants (NOACs), which are being prescribed to treat patients with a serious medical condition known as atrial fibrillation. A person with this disease has an irregular heartbeat not caused by a valve defect that can cause large blood clots to form deep in a patient’s veins. The clots can break free in a condition known as deep vein thrombosis (DVT) and travel through the patient’s circulatory system, where they can rupture in the lungs in what is known as a pulmonary embolism (PE), or they can block the flow of blood to the brain causing a stroke.  Continue reading

Contact Information